ATTENTIONAL PERFORMANCE IN POSITIVE-SYMPTOM AND NEGATIVE-SYMPTOM SCHIZOPHRENIA

被引:73
|
作者
GREEN, M
WALKER, E
机构
[1] CORNELL UNIV,DEPT HUMAN DEV & FAMILY STUDIES,ITHACA,NY 14853
[2] CORNELL UNIV,DEPT PSYCHOL,ITHACA,NY 14853
关键词
D O I
10.1097/00005053-198604000-00003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:208 / 213
页数:6
相关论文
共 50 条
  • [41] ELECTROCONVULSIVE-THERAPY AND NEUROLEPTIC MEDICATION IN THERAPY-RESISTANT POSITIVE-SYMPTOM PSYCHOSIS
    GUJAVARTY, K
    GREENBERG, LB
    FINK, M
    CONVULSIVE THERAPY, 1987, 3 (03): : 185 - 195
  • [42] Multifunctional Pharmacotherapy: What Can We Learn from Study of Selective Serotonin Reuptake Inhibitor Augmentation of Antipsychotics in Negative-Symptom Schizophrenia?
    Silver, Henry
    Chertkow, Yael
    Weinreb, Orly
    Danovich, Lena
    Youdim, Moussa
    NEUROTHERAPEUTICS, 2009, 6 (01) : 86 - 93
  • [43] The effect of positive symptom ratings on negative symptom ratings differs over time
    Alvir, JMJ
    Lieberman, JA
    Woerner, MG
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 409 - 409
  • [44] Attributions of causality, responsibility and blame for positive and negative symptom behaviours in caregivers of persons with schizophrenia
    Provencher, HL
    Fincham, FD
    PSYCHOLOGICAL MEDICINE, 2000, 30 (04) : 899 - 910
  • [45] Processing speed and visual sustained attention in patients with predominantly positive and negative symptom schizophrenia
    Farella-Busch, S
    Berns, S
    Jaeger, J
    Halperin, J
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2000, 15 (08) : 762 - 762
  • [46] Multifunctional pharmacotherapy: What can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?
    Henry Silver
    Yael Chertkow
    Orly Weinreb
    Lena Danovich
    Moussa Youdim
    Neurotherapeutics, 2009, 6 : 86 - 93
  • [47] Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia
    Leucht, Stefan
    Barabassy, Agota
    Laszlovszky, Istvan
    Szatmari, Balazs
    Acsai, Karoly
    Szalai, Erzsebet
    Harsanyi, Judit
    Earley, Willie
    Nemeth, Gyorgy
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (09) : 1589 - 1596
  • [48] Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia
    Stefan Leucht
    Ágota Barabássy
    István Laszlovszky
    Balázs Szatmári
    Károly Acsai
    Erzsébet Szalai
    Judit Harsányi
    Willie Earley
    György Németh
    Neuropsychopharmacology, 2019, 44 : 1589 - 1596
  • [49] REWARD SYSTEM DYSFUNCTION AND NEGATIVE SYMPTOM DIMENSIONS IN SCHIZOPHRENIA
    Kirschner, Matthias
    Hager, Oliver
    Hartmann, Matthias
    Kluge, Agne
    Bischof, Martin
    Seifritz, Erich
    Tobler, Philippe
    Kaiser, Stefan
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S331 - S332
  • [50] NEGATIVE SYMPTOM ASSESSMENT OF CHRONIC-SCHIZOPHRENIA PATIENTS
    RASKIN, A
    PELCHAT, R
    SOOD, R
    ALPHS, LD
    LEVINE, J
    SCHIZOPHRENIA BULLETIN, 1993, 19 (03) : 627 - 635